MOTS-C

MOTS-C 10MG

MOTS-C is an investigational 16–amino acid mitochondrial-derived peptide engineered for research into metabolic resilience, exercise mimetics, and healthy aging biology, acting at the interface of mitochondrial signaling and nuclear gene regulation to support cellular homeostasis under stress. By engaging pathways such as AMPK and folate–purine metabolism, MOTS-C has been shown in preclinical and early human work to enhance glucose utilization, improve stress resistance, and favorably influence body composition and physical performance, positioning it as a powerful tool for scientists exploring insulin resistance, sarcopenia, and age-related functional decline. As a next-generation “mitokine” candidate, MOTS-C allows investigators to probe how targeted modulation of mitochondrial peptides may translate into systemic benefits across muscle, cardiovascular, bone, and inflammatory domains, while remaining strictly intended for controlled research use only.